White Paper

Essential Elements Of A Data Management Plan For Outsourced Drug Development

By Bikash Chatterjee

Medical scientists analyzing research-GettyImages-1413600685

Bringing innovative and life-sustaining drugs to the world is the mission of the pharmaceutical industry, but historically, the time, cost, and effort to bring new drugs to market has been a challenge, with only 13% of all drugs in development taking up to 10 years to be launched commercially. However, the global need for a COVID-19 vaccine redefined the rules of drug development. The benefits of harnessing data efficiently and effectively have never been more apparent. To most pharma organizations, that means establishing a digital integration or transformation strategy and linking that to a comprehensive data management plan.

As drug sponsors extend the development and manufacturing enterprise to include CDMO partners, the ability to rapidly and accurately share access to relevant data can have a profound impact on both time to market and simplifying program decision-making. Understanding the key characteristics of an effective data management plan as they relate to contract service providers is important in developing an effective data management plan.

access the White Paper!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Bioprocess Online

Pharmatech Associates - A USP Company